Blacksmith Medicines Gets Seed Funding
socalTECH
JANUARY 8, 2021
San Diego-based Blacksmith Medicines, a new biotechnology company focused on creating medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, has raised a round of seed funding, and announced a research deal with Lilly. Financial details of that seed funding were not announced.
Let's personalize your content